Browse Category
Stock Market 4 February 2026
Alphabet shares fell about 5.6%, continuing their decline from May highs as investors expressed concerns over AI-related costs, new share sales, and further management changes. Despite this, Citizens maintained its Market Outperform rating and a $515 price target. AMC reported strong attendance for Toy Story 5, with over 4.8 million viewers at AMC Theatres and Odeon Cinemas, but its shares edged down to $2.79. The S&P 500 and Dow rose, with the Dow gaining 214.78 points, while the Nasdaq declined due to losses in large-cap tech stocks outweighing gains in chip stocks. Brent crude dropped below $79 as U.S.-Iran talks progressed, but U.S. 10-year yields continued to rise. TSMC’s U.S.-listed shares outperformed tech and chip ETFs, with June sales seen as a key catalyst, though risks remain tied to AI capacity spending. Marathon Digital Holdings (MARA) surged 12.8%, outperforming bitcoin and peers, as bitcoin ETF flows remained soft and institutional demand weak. Apogee Therapeutics jumped 47% after AbbVie agreed to acquire it for $135.11 per share, adding a late-stage IL-13 antibody to AbbVie’s portfolio. SK Hynix’s market cap surpassed Samsung Electronics for the first time since 2000, driven by high-bandwidth memory demand in the AI supply chain. Netflix shares rose 0.5% ahead of its July 16 Q2 earnings, with investors focused on ads, pricing, and margins. Definium’s Phase 3 trial for DT120 met its primary endpoint in major depressive disorder, boosting its shares. CRH will acquire Arcosa for $150 per share, expanding its U.S. aggregates and energy transmission assets.